Labeler
Rising Pharma Holdings, Inc. NDC Codes
Rising Pharma Holdings, Inc. lists 542 finished drug products in the FDA NDC Directory under NDC labeler codes 16571, 57237, 64980.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Buspirone Hydrochloride, Memantine Hydrochloride, Albuterol Sulfate, Enalapril Maleate, Amlodipine Besylate, Spironolactone, Lorazepam, sumatriptan, Mexiletine Hydrochloride, Mesalamine, Glipizide, Aminocaproic Acid, Oxybutynin Chloride, azithromycin, Dimetane
- Active ingredients
- Buspirone hydrochloride, Albuterol sulfate, Memantine hydrochloride, Enalapril maleate, Amlodipine besylate, Spironolactone, Lorazepam, Acetaminophen, Sumatriptan succinate, Cyclobenzaprine hydrochloride, Mexiletine hydrochloride, Mesalamine
- NDC labeler codes
- 16571, 57237, 64980
- Strengths (from the 100 most recently listed products)
- Guaifenesin 100 mg/5mL; Cetirizine hydrochloride 1 mg/mL; Mesalamine 4 g/60mL; Glipizide 5 mg/1; Glipizide 10 mg/1; Clopidogrel bisulfate 75 mg/1; Tramadol hydrochloride 25 mg/1; Chlorhexidine gluconate 1.2 mg/mL; Mycophenolate mofetil 200 mg/mL; Bisacodyl 5 mg/1; Sennosides 8.6 mg/1; Aminocaproic acid 1000 mg/1; Aminocaproic acid 500 mg/1; Phenoxybenzamine hydrochloride 10 mg/1; Famotidine 40 mg/5mL; Oxybutynin chloride 2.5 mg/1; Amlodipine besylate 2.5 mg/1; Amlodipine besylate 5 mg/1; Amlodipine besylate 10 mg/1; Alfuzosin hydrochloride 10 mg/1
- Dosage forms
- Tablet, Solution, Tablet, Film coated, Cream, Capsule, Capsule, Extended release, Liquid, Suppository, Tablet, Delayed release, Powder, For suspension, Capsule, Liquid filled, Inhalant, Tablet, Extended release, Suspension, Tablet, Coated, Tablet, Film coated, Extended release, Capsule, Delayed release, Injection, Solution
- Routes
- Oral, Respiratory (Inhalation), Topical, Rectal, Ophthalmic, Intramuscular
- Drug classes (FDA established)
- Histamine-1 Receptor Antagonist, beta2-Adrenergic Agonist, Antiarrhythmic, N-methyl-D-aspartate Receptor Antagonist, Angiotensin Converting Enzyme Inhibitor, Aminosalicylate, Histamine-2 Receptor Antagonist, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Proton Pump Inhibitor, Aldosterone Antagonist, Benzodiazepine, Anticholinergic, Serotonin-1b and Serotonin-1d Receptor Agonist, Muscle Relaxant, Sulfonylurea, Antifibrinolytic Agent, alpha-Adrenergic Blocker, Cholinergic Muscarinic Antagonist, Macrolide Antimicrobial, Expectorant, Non-Standardized Chemical Allergen, Monoamine Oxidase Inhibitor, beta-Adrenergic Blocker, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Corticosteroid, Osmotic Laxative, Potassium Salt, P2Y12 Platelet Inhibitor, Opioid Agonist, Antimetabolite Immunosuppressant, Stimulant Laxative, Catechol-O-Methyltransferase Inhibitor, Lincosamide Antibacterial, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Amide Local Anesthetic, Cephalosporin Antibacterial, Carbonic Anhydrase Inhibitor, Azole Antifungal, Copper Absorption Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Central Nervous System Stimulant, Methylxanthine, Central alpha-2 Adrenergic Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 186 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Spironolactone | Spironolactone 50 mg/1 | TabletOral | 64980-707 | 64980-0707-0164980-0707-50 | — |
| Spironolactone | Spironolactone 100 mg/1 | TabletOral | 64980-708 | 64980-0708-0164980-0708-50 | — |
| Proctozone-Gglycerin | Glycerin 1.2 g/1 | SuppositoryRectal | 57237-338 | 57237-0338-2157237-0338-52 | — |
| Proctozone GMaxglycerin | Glycerin 2 g/1 | SuppositoryRectal | 57237-339 | 57237-0339-2157237-0339-52 | — |
| Lorazepam | Lorazepam .5 mg/1 | TabletOral | 64980-627 | 64980-0627-0164980-0627-1064980-0627-50 | — |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | 64980-628 | 64980-0628-0164980-0628-1064980-0628-50 | — |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | 64980-629 | 64980-0629-0164980-0629-1064980-0629-50 | — |
| Rasagilinerasagiline mesylate | Rasagiline mesylate 1 mg/1 | TabletOral | 64980-712 | 64980-0712-30 | — |
| Rasagilinerasagiline mesylate | Rasagiline mesylate .5 mg/1 | TabletOral | 64980-711 | 64980-0711-30 | — |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | 16571-806 | 16571-0806-06 | — |
| Bisoprolol Fumarate | Bisoprolol fumarate 5 mg/1 | Tablet, Film coatedOral | 64980-709 | 64980-0709-0164980-0709-03 | — |
| Bisoprolol Fumarate | Bisoprolol fumarate 10 mg/1 | Tablet, Film coatedOral | 64980-710 | 64980-0710-0164980-0710-03 | — |
| Acetaminophen | Acetaminophen 325 mg/1 | Tablet, Film coatedOral | 57237-346 | 57237-0346-0157237-0346-10 | — |
| Acetaminophen | Acetaminophen 500 mg/1 | Tablet, Film coatedOral | 57237-347 | 57237-0347-0157237-0347-05 | — |
| Acetaminophen, Aspirin and Caffeine | Acetaminophen 250 mg/1 + 2 more ingredients | TabletOral | 57237-348 | 57237-0348-01 | — |
| Adult Low Dose Aspirinaspirin | Aspirin 81 mg/1 | Tablet, Delayed releaseOral | 57237-349 | 57237-0349-1057237-0349-12 | — |
| Dicyclomine Hydrochloride | Dicyclomine hydrochloride 10 mg/1 | CapsuleOral | 16571-260 | 16571-0260-0116571-0260-10 | — |
| Memantine Hydrochloridememantine | Memantine hydrochloride 21 mg/1 | Capsule, Extended releaseOral | 16571-854 | 16571-0854-03 | — |
| Memantine Hydrochloridememantine | Memantine hydrochloride 7 mg/1 | Capsule, Extended releaseOral | 16571-852 | 16571-0852-03 | — |
| Memantine Hydrochloridememantine | Memantine hydrochloride 14 mg/1 | Capsule, Extended releaseOral | 16571-853 | 16571-0853-0316571-0853-09 | — |
| Memantine Hydrochloridememantine | Memantine hydrochloride 28 mg/1 | Capsule, Extended releaseOral | 16571-855 | 16571-0855-0316571-0855-09 | — |
| sumatriptan | Sumatriptan succinate 50 mg/1 | Tablet, Film coatedOral | 64980-661 | 64980-0661-2764980-0661-3664980-0661-91 | — |
| sumatriptan | Sumatriptan succinate 25 mg/1 | Tablet, Film coatedOral | 64980-660 | 64980-0660-2764980-0660-3664980-0660-91 | — |
| sumatriptan | Sumatriptan succinate 100 mg/1 | Tablet, Film coatedOral | 64980-662 | 64980-0662-2764980-0662-3664980-0662-91 | — |
| olopatadine hydrochloride | Olopatadine hydrochloride 2 mg/mL | SolutionOphthalmic | 16571-861 | 16571-0861-25 | — |
| olopatadine hydrochloride | Olopatadine hydrochloride 1 mg/mL | SolutionOphthalmic | 16571-882 | 16571-0882-05 | — |
| Ipratropium Bromide | Ipratropium bromide .5 mg/2.5mL | SolutionRespiratory (Inhalation) | 64980-640 | 64980-0640-0264980-0640-0364980-0640-06 | — |
| Albuterol Sulfate | Albuterol sulfate 2.5 mg/.5mL | SolutionRespiratory (Inhalation) | 64980-642 | 64980-0642-03 | — |
| Albuterol Sulfate | Albuterol sulfate .63 mg/3mL | SolutionRespiratory (Inhalation) | 64980-643 | 64980-0643-03 | — |
| Albuterol Sulfate | Albuterol sulfate 1.25 mg/3mL | SolutionRespiratory (Inhalation) | 64980-644 | 64980-0644-02 | — |
| Mesalamine | Mesalamine 1000 mg/1 | SuppositoryRectal | 16571-246 | 16571-0246-0316571-0246-72 | — |
| Methyldopa | Methyldopa 250 mg/1 | TabletOral | 64980-571 | 64980-0571-01 | — |
| Budesonide | Budesonide .25 mg/2mL | InhalantRespiratory (Inhalation) | 64980-638 | 64980-0638-03 | — |
| Budesonide | Budesonide .5 mg/2mL | InhalantRespiratory (Inhalation) | 64980-639 | 64980-0639-03 | — |
| Albuterol Sulfate | Albuterol sulfate 2.5 mg/3mL | SolutionRespiratory (Inhalation) | 64980-641 | 64980-0641-0264980-0641-0364980-0641-06 | — |
| Ipratropium Bromide and Albuterol Sulfate | Ipratropium bromide .5 mg/3mL; Albuterol sulfate 3 mg/3mL | SolutionRespiratory (Inhalation) | 64980-645 | 64980-0645-0364980-0645-06 | — |
| Pantoprazole Sodium | Pantoprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | 64980-676 | 64980-0676-09 | — |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Tablet, Delayed releaseOral | 64980-677 | 64980-0677-0964980-0677-10 | — |
| Fexmidcyclobenzaprine hydrochloride | Cyclobenzaprine hydrochloride 7.5 mg/1 | TabletOral | 64980-705 | 64980-0705-0164980-0705-50 | — |
| Enalapril Maleate | Enalapril maleate 2.5 mg/1 | TabletOral | 64980-685 | 64980-0685-0164980-0685-10 | — |
| Enalapril Maleate | Enalapril maleate 20 mg/1 | TabletOral | 64980-688 | 64980-0688-0164980-0688-10 | — |
| Enalapril Maleate | Enalapril maleate 5 mg/1 | TabletOral | 64980-686 | 64980-0686-0164980-0686-10 | — |
| Enalapril Maleate | Enalapril maleate 10 mg/1 | TabletOral | 64980-687 | 64980-0687-0164980-0687-10 | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 5 mg/1 | TabletOral | 64980-655 | 64980-0655-0164980-0655-1064980-0655-50 | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 10 mg/1 | TabletOral | 64980-657 | 64980-0657-0164980-0657-1064980-0657-50 | — |
| Potassium Chloride Extended Releasepotassium chloride | Potassium chloride 600 mg/1 | Tablet, Extended releaseOral | 16571-842 | 16571-0842-0116571-0842-1016571-0842-50 | — |
| Potassium Chloride Extended Releasepotassium chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | 16571-843 | 16571-0843-0116571-0843-1016571-0843-50 | — |
| Mexiletine Hydrochloride | Mexiletine hydrochloride 250 mg/1 | CapsuleOral | 64980-668 | 64980-0668-01 | — |
| Mexiletine Hydrochloride | Mexiletine hydrochloride 150 mg/1 | CapsuleOral | 64980-666 | 64980-0666-01 | — |
| Mexiletine Hydrochloride | Mexiletine hydrochloride 200 mg/1 | CapsuleOral | 64980-667 | 64980-0667-01 | — |
Rising Pharma Holdings, Inc.: common questions
- What is Rising Pharma Holdings, Inc.'s NDC labeler code?
- 16571, 57237, 64980. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Rising Pharma Holdings, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.